MacLennan S et al. – The evidence base suggests localised Renal cell carcinomas are best managed by nephron–sparing surgery where technically feasible. However, the current evidence base has significant limitations due to studies of low methodological quality marked by high risks of bias. [more...]
© 2015 M3 USA Corporation. ALL Rights Reserved.